Ads
related to: Novavax Vaccine
Search results
Shah Capital proposes new directors for Novavax board By Investing.com
Investing.com· 4 days agoShah Capital, holding a 6.7% stake in vaccine developer Novavax Inc. (NASDAQ: NASDAQ:NVAX), today...
Who can get a Covid booster this spring and how can you book?
BBC via Yahoo News· 6 days agoThey are part of the body's normal immune response to vaccination, and tend to resolve within a day...
Novavax failed to capitalize on fears surrounding mRNA vaccines, activist investor says
Market Watch· 4 days agovaccine-maker’s management, as it called for an overhaul of the company’s marketing strategy to...
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
Quartz· 4 days agoThe activist hedge fund Shah Capital blasted the leadership of Novavax for not leveraging concerns...
Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?
Zacks via Yahoo Finance· 1 week agoTo extend its existing cash runway and curb cash burn, Novavax (NVAX) initiates multiple...
Only One Harm From mRNA COVID Vaccines, Report Determines
MedPage Today· 4 days agoIndependent reviewers confirmed a causal relationship between the first mRNA COVID-19 vaccines and...
Novavax investor Shah Capital pushes for board shakeup
Reuters via AOL· 4 days ago(Reuters) -A top shareholder of COVID-19 vaccine maker Novavax on Monday said the company has been...
The path to a better Tuberculosis vaccine runs through Montana
The Norman Transcript· 6 hours agoA team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people ...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 8 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 1 day agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...